Barclays PLC Sells 93,416 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Barclays PLC cut its holdings in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 57.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,111 shares of the semiconductor company's stock after selling 93,416 shares during the quarter. Barclays PLC owned 0.21% of Axcelis Technologies worth $7,143,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Van ECK Associates Corp grew its stake in Axcelis Technologies by 40.0% during the third quarter. Van ECK Associates Corp now owns 23,751 shares of the semiconductor company's stock worth $2,490,000 after buying an additional 6,786 shares in the last quarter. Royce & Associates LP lifted its holdings in shares of Axcelis Technologies by 157.1% during the 3rd quarter. Royce & Associates LP now owns 273,671 shares of the semiconductor company's stock worth $28,694,000 after acquiring an additional 167,235 shares during the period. Harbor Capital Advisors Inc. boosted its position in shares of Axcelis Technologies by 243.8% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 60,328 shares of the semiconductor company's stock worth $6,325,000 after acquiring an additional 42,779 shares in the last quarter. Annex Advisory Services LLC increased its stake in Axcelis Technologies by 72.0% in the third quarter. Annex Advisory Services LLC now owns 12,226 shares of the semiconductor company's stock valued at $1,282,000 after acquiring an additional 5,118 shares during the last quarter. Finally, FMR LLC raised its position in Axcelis Technologies by 51.4% during the third quarter. FMR LLC now owns 263,332 shares of the semiconductor company's stock valued at $27,610,000 after purchasing an additional 89,453 shares in the last quarter. 89.98% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

ACLS has been the topic of a number of research analyst reports. Benchmark lowered Axcelis Technologies from a "buy" rating to a "hold" rating in a research note on Friday, November 8th. Needham & Company LLC reaffirmed a "hold" rating on shares of Axcelis Technologies in a research note on Friday, November 8th. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of $167.33.

Axcelis Technologies Price Performance

ACLS traded down $1.79 on Thursday, reaching $69.18. The stock had a trading volume of 673,862 shares, compared to its average volume of 629,656. The company has a current ratio of 4.45, a quick ratio of 3.29 and a debt-to-equity ratio of 0.04. The company has a market capitalization of $2.25 billion, a price-to-earnings ratio of 10.23, a price-to-earnings-growth ratio of 2.36 and a beta of 1.53. Axcelis Technologies, Inc. has a fifty-two week low of $68.79 and a fifty-two week high of $158.61. The firm has a 50-day moving average of $82.48 and a 200-day moving average of $106.47.

Axcelis Technologies Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.